Viewing Study NCT02963766


Ignite Creation Date: 2025-12-24 @ 4:14 PM
Ignite Modification Date: 2026-02-23 @ 8:31 PM
Study NCT ID: NCT02963766
Status: COMPLETED
Last Update Posted: 2022-07-01
First Post: 2016-11-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes
Sponsor: Eli Lilly and Company
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 14171
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators